The purpose of this study was to investigate if the levonorgestrel-impregnated intrauterine device ( LNG-IUS , Mirena ( ) ) is safe and effective as therapy for low-risk and medium-risk endometrial hyperplasia compared with oral medroxyprogesterone ( MPA ) .